We just received data on a new analyst forecast for $RXO. J. Bruce Chan from Stifel set a price target of 22.0 for RXO.
To track analyst ratings and price targets for $RXO, check out Quiver Quantitative's $RXO forecast page.
Should you buy $RXO?
Some analysts are better than others. To view the past performance of Stifel, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$RXO Price Targets
Multiple analysts have issued price targets for $RXO recently. We have seen 10 analysts offer price targets for $RXO in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- J. Bruce Chan from Stifel set a target price of $22.0 on 05/15/2026
- Ravi Shanker from Morgan Stanley set a target price of $22.0 on 05/08/2026
- Christian Wetherbee from Wells Fargo set a target price of $22.0 on 05/08/2026
- Bascome Majors from Susquehanna set a target price of $18.0 on 05/08/2026
- Brandon Oglenski from Barclays set a target price of $20.0 on 05/08/2026
- Lucas Servera from Truist Securities set a target price of $26.0 on 05/08/2026
- Ariel Rosa from Citigroup set a target price of $24.0 on 05/08/2026
$RXO Insider Trading Activity
$RXO insiders have traded $RXO stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:
- PARTNERS, LP MFN purchased 532,276 shares for an estimated $6,387,312
- ADRIAN KINGSHOTT purchased 9,350 shares for an estimated $100,512
- TROY A. COOPER purchased 8,317 shares for an estimated $88,243
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$RXO Revenue
$RXO had revenues of $1.4B in Q1 2026. This is a decrease of -0.56% from the same period in the prior year.
You can track RXO financials on Quiver Quantitative's RXO stock page.
You can access data on RXO stock through the Quiver Quantitative API.
$RXO Hedge Fund Activity
We have seen 135 institutional investors add shares of $RXO stock to their portfolio, and 137 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 5,287,097 shares (-52.9%) from their portfolio in Q4 2025, for an estimated $66,828,906
- BOSTON PARTNERS added 2,497,016 shares (+inf%) to their portfolio in Q1 2026, for an estimated $36,506,373
- ORBIS ALLAN GRAY LTD added 2,104,597 shares (+6.5%) to their portfolio in Q4 2025, for an estimated $26,602,106
- NORGES BANK removed 1,078,164 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $13,627,992
- KENNEDY CAPITAL MANAGEMENT LLC added 976,475 shares (+135.7%) to their portfolio in Q1 2026, for an estimated $14,276,064
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 888,005 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $12,982,633
- FINEPOINT CAPITAL LP added 684,829 shares (+7.3%) to their portfolio in Q1 2026, for an estimated $10,012,199
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
